NCT02422784

Brief Summary

This is a cross-sectional study designed to compare plasma/serum and urine vitamin D metabolite profiles of vitamin D sufficient and insufficient individuals. There are two phases of this study. Phase 1 - Consented study participants will attend a screening visit and provide a fasting blood and urine sample. Those individuals who are vitamin D insufficient based on serum 25(OH)D concentrations will be invited to participate in Phase II Phase II - is a double-blind, randomized, control study designed to examine vitamin D status in vitamin D insufficient individuals consuming a water-soluble form of vitamin D3. Eligible participants will be asked to consume one of three beverages: i) rooibos iced-tea (control); ii) rooibos iced-tea fortified with 1000 IU of water-soluble vitamin D3; or iii) rooibos iced-tea fortified with 1000 IU of water-soluble vitamin D3 and 360 mg calcium at 240 mL of iced-tea consumed daily for 6 weeks. Participants will attend 6 weekly visits following baseline and provide a fasting blood sample for assessment of serum 25(OH)D concentrations. Objectives: 1) To investigate plasma/serum and urine vitamin D metabolite profiles in vitamin D sufficient and insufficient individuals; and 2) To determine the effects of vitamin D3 fortification on serum 25-dihydroxy-vitamin D \[25(OH)D\] concentrations, markers of vitamin D and calcium metabolism, and vitamin D metabolite profile in plasma/serum and urine of vitamin D insufficient individuals.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jul 2016

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 11, 2015

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 21, 2015

Completed
1.2 years until next milestone

Study Start

First participant enrolled

July 1, 2016

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2018

Completed
Last Updated

February 23, 2017

Status Verified

March 1, 2016

Enrollment Period

1.9 years

First QC Date

February 11, 2015

Last Update Submit

February 22, 2017

Conditions

Keywords

Vitamin D insufficientrooibos teacalcium

Outcome Measures

Primary Outcomes (2)

  • Plasma/Serum and Urine Vitamin D Metabolite Profiles of Vitamin D Sufficient and Insufficient Individuals

    To investigate plasma/serum and urine vitamin D metabolite profiles in vitamin D sufficient and insufficient individuals.

    Screening Visit (Day 0) - Phase 1

  • The Effects of Vitamin D Fortification on Serum 25(OH)D in Vitamin D Insufficient Individuals.

    To determine the effects of 6 weeks of vitamin D3 fortification on serum 25-dihydroxy-vitamin D \[25(OH)D\] concentrations of vitamin D insufficient individuals.

    6 Weeks (Phase II)

Secondary Outcomes (3)

  • The Effects of Vitamin D3 Fortification on markers of vitamin D of vitamin D insufficient individuals

    6 Weeks (Phase II)

  • The Effects of vitamin D3 Fortification on calcium metabolism of Vitamin D Insufficient Individuals.

    6 Weeks (Phase II)

  • The Effects of Vitamin D3 Fortification on Vitamin D Metabolite Profile of Vitamin D Insufficient Individuals.

    6 Weeks (Phase II)

Study Arms (3)

Control

PLACEBO COMPARATOR

Participants will be instructed to consume 240 mL of iced-tea daily for 6 weeks. The iced-tea beverages do not contain added sugar or artificial sweeteners. Beverages will be prepared fresh weekly and picked up by participants during their weekly study visits.

Dietary Supplement: Rooibos Iced-Tea (Control)

Rooibos Tea - Vitamin D3

ACTIVE COMPARATOR

Participants will be instructed to consume 240 mL of iced-tea fortified with 1000 IU water-soluable vitamin D3 daily for 6 weeks. The iced-tea beverages do not contain added sugar or artificial sweeteners. Beverages will be prepared fresh weekly and picked up by participants during their weekly study visits.

Dietary Supplement: Rooibos Tea - Vitamin D3

Rooibos Tea- Vitamin D3 & Calcium

ACTIVE COMPARATOR

Participants will be instructed to consume 240 mL of Rooibos iced-tea fortified with 1000 IU of water-soluable vitamin D3 and 360 mg of calcium daily for 6 weeks. The iced-tea beverages do not contain added sugar or artificial sweeteners. Beverages will be prepared fresh weekly and picked up by participants during their weekly study visits.

Dietary Supplement: Rooibos Tea- Vitamin D3 & Calcium

Interventions

Rooibos Iced-Tea (Control)DIETARY_SUPPLEMENT

Participants will consume 240 mL of Rooibos iced-tea daily for 6 weeks. The iced-tea beverage will not contain any added sugar or artificial sweeteners. Beverages will be prepared fresh weekly and picked up by participants during their weekly study visits.

Control
Rooibos Tea - Vitamin D3DIETARY_SUPPLEMENT

Participants will consume 240 mL of Rooibos iced-tea fortified with 1000 IU of water soluable Vitamin D3 daily for 6 weeks. The iced-tea beverage will not contain any added sugar or artificial sweeteners. Beverages will be prepared fresh weekly and picked up by participants during their weekly study visits.

Rooibos Tea - Vitamin D3

Participants will consume 240 mL of Rooibos iced-tea fortified with 1000 IU of water soluable Vitamin D3 and 360 mg of Calicum daily for 6 weeks. The iced-tea beverage will not contain any added sugar or artificial sweeteners. Beverages will be prepared fresh weekly and picked up by participants during their weekly study visits.

Rooibos Tea- Vitamin D3 & Calcium

Eligibility Criteria

Age19 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Adult volunteers, male or female, between 19 and 50 years of age;
  • Body mass index (BMI) ≥20 and ≤30 kg/m2 (normal to overweight);
  • Must be on a stable regime for the past three months, if taking vitamin and mineral/dietary/herbal supplements; and
  • Willing to provide informed consent.
  • Adult volunteers, male or female, between 19 and 50 years of age;
  • Body mass index (BMI) ≥20 and ≤30 kg/m2 (normal to overweight);
  • Must be on a stable regime for the past three months, if taking vitamin and mineral/dietary/herbal supplements;
  • Vitamin D insufficient (serum 25(OH)D concentrations ≥30 and ≤75 nmol/L);
  • Willing to comply with protocol requirements; and
  • Willing to provide informed consent.

You may not qualify if:

  • Take a vitamin D or calcium supplement within the last three months before the start date of the study, or during the study;
  • History of vitamin D deficiency (serum 25(OH)D concentration \<30 nmol/L);
  • History of hypocalcaemia;
  • Presence of a clinically diagnosed disease affecting the circulatory, respiratory, immune, skeletal, urinary, muscular, endocrine, digestive, nervous or reproductive system that requires medical treatment;
  • Taking any medication (with the exception of birth control);
  • Daily consumption of more than three servings of dairy products;
  • Undergone significant sun exposure one month before start date of the study;
  • Use or have used a tanning booth one month before start date of the study, or during the study;
  • Plan to travel to a sunny climate during the study;
  • Currently smoking or have smoked within the last six months before start date of the study, or during the study;
  • Have allergies to tea products;
  • Pregnant or lactating; and
  • Consume excessive alcohol (\>10 drinks/week for women, \>15 drinks/week for men).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Boniface Hospital, Asper Clinical Research Institute

Winnipeg, Manitoba, R2H 2A6, Canada

Location

Related Publications (5)

  • Calvo MS, Whiting SJ, Barton CN. Vitamin D fortification in the United States and Canada: current status and data needs. Am J Clin Nutr. 2004 Dec;80(6 Suppl):1710S-6S. doi: 10.1093/ajcn/80.6.1710S.

    PMID: 15585792BACKGROUND
  • Tangpricha V, Koutkia P, Rieke SM, Chen TC, Perez AA, Holick MF. Fortification of orange juice with vitamin D: a novel approach for enhancing vitamin D nutritional health. Am J Clin Nutr. 2003 Jun;77(6):1478-83. doi: 10.1093/ajcn/77.6.1478.

    PMID: 12791627BACKGROUND
  • Ding S, Schoenmakers I, Jones K, Koulman A, Prentice A, Volmer DA. Quantitative determination of vitamin D metabolites in plasma using UHPLC-MS/MS. Anal Bioanal Chem. 2010 Sep;398(2):779-89. doi: 10.1007/s00216-010-3993-0. Epub 2010 Jul 14.

    PMID: 20628873BACKGROUND
  • Luque de Castro MD, Fernandez-Romero JM, Ortiz-Boyer F, Quesada JM. Determination of vitamin D3 metabolites: state-of-the-art and trends. J Pharm Biomed Anal. 1999 Jun;20(1-2):1-17. doi: 10.1016/s0731-7085(99)00027-8.

    PMID: 10704005BACKGROUND
  • Stalmach A, Mullen W, Pecorari M, Serafini M, Crozier A. Bioavailability of C-linked dihydrochalcone and flavanone glucosides in humans following ingestion of unfermented and fermented rooibos teas. J Agric Food Chem. 2009 Aug 12;57(15):7104-11. doi: 10.1021/jf9011642.

    PMID: 19534535BACKGROUND

Related Links

MeSH Terms

Conditions

Vitamin D Deficiency

Interventions

Calcium

Condition Hierarchy (Ancestors)

AvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Metals, Alkaline EarthElementsInorganic ChemicalsMetalsBlood Coagulation FactorsBiological Factors

Study Officials

  • Carla Taylor, PhD

    University of Manitoba

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 11, 2015

First Posted

April 21, 2015

Study Start

July 1, 2016

Primary Completion

June 1, 2018

Study Completion

June 1, 2018

Last Updated

February 23, 2017

Record last verified: 2016-03

Locations